LAS VEGAS, NV / ACCESSWIRE / April 5, 2016 / Medical cannabis testing is set to become stricter than ever in Colorado, and Neutra Corp. (OTCQB: NTRR) is working to deliver solutions to help cultivators produce crops that comply with state regulations.
Last month, Westword reported that the Colorado House passed House Bill 16-1064, which enables facilities to get a medical marijuana testing license in anticipation of required testing to come. Medical cannabis products, including edibles and topicals, will be required to undergo testing by state-certified facilities, much as non-medical, adult-use cannabis products are tested already. Colorado's state Senate passed the proposal on March 8.
"Testing has become a priority in Colorado and elsewhere in part due to fears over pesticide usage in cannabis cultivation," said NTRR CEO Chris Brown. "The marketplace is beginning to insist on complete transparency with regard to the chemicals they may potentially be ingesting."
NTRR is marketing new, potentially healthier alternatives to harsh chemicals in cannabis cultivation. Alongside joint venture partner Surface to Air Solutions (S2O2), the company offers cannabis growers and other businesses a suite of horticultural products—including a plant stimulant, an air-scrubber and a self-cleaning hard surface treatment. Used together, the suite of products helps keep plants healthy and strong.
With analysts predicting that the U.S. cannabis industry could grow by another six states in 2016, NTRR will continue to seek out products to capitalize on the historic growth of cannabis throughout North America.
About Neutra Corp.
Neutra Corp. is a healthy lifestyle company that specializes in the development and marketing of natural wellness solutions, including cannabis-related products. By providing a variety of new technologies designed to ensure safer, more reliable access to cannabis in approved markets, Neutra Corp. plans to compete alongside GW Pharmaceuticals (NASDAQ: GWPRF), INSYS Therapeutics, Inc. (NASDAQ: INSY) and ENDEXX Corp. (NASDAQ: EDXC), delivering technological advancements in the cultivation and processing of cannabis in approved markets. For investing information and performance data, please visit www.neutrainc.com.
Notice Regarding Forward-Looking Statements
Safe Harbor Statement under the Private Securities Litigation Reform Act of 1995: This news release contains forward-looking information within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended, including statements that include the words "believes," "expects," "anticipate" or similar expressions. Such forward-looking statements involve known and unknown risks, uncertainties and other factors that may cause the actual results, performance or achievements of the Company to differ materially from those expressed or implied by such forward-looking statements. In addition, description of anyone's past success, either financial or strategic, is no guarantee of success. This news release speaks as of the date first set forth above and the Company assumes no responsibility to update the information included herein for events occurring after the date hereof.
Neutra Corp.
Chris Brown, 813-367-2041
President and CEO
info@neutrainc.com
SOURCE: Neutra Corp.
ReleaseID: 438452
